Mr. Kow Chia Siang
Kow Chia Siang graduated with a Bachelor of Pharmacy (Hons) and Master in Pharmacy Practice from the International Medical University, Kuala Lumpur, Malaysia. He is a registered pharmacist with the Pharmacy Board of Malaysia. Prior to joining Monash University Malaysia, he worked primarily in Malaysia across different pharmacy practice settings, as a primary care pharmacist, and had experience in clinical departments in tertiary care hospital. He is also trained to provide Methadone Replacement Therapy (MRT) and smoking cessation service. Chia Siang has a keen interest in the research areas related to the quality use of medications, pharmacy practice, and coronavirus disease.
- Master in Pharmacy Practice, International Medical University, 2021
- Bachelor of Pharmacy (Hons), International Medical University, 2017
Registered Pharmacist, since 2018
Pharmacy Board of Malaysia
Member, since 2017
Malaysian Pharmacists Society
Awards and Honours
- Dean's List, International Medical University, School of Pharmacy
- Champion in 3rd MyPSA National Clinical Pharmacy Challenge
- Best presenter in 3rd MyPSA National Clinical Pharmacy Challenge
- Quality Use of Medications / Medication Appropriateness
- Pharmacy Practice
- Clinical Pharmacy
- Evidence-based Medicine
- Coronavirus (COVID-19)
Scholarly Journals (Refereed Only)
Kow CS, Merchant HA, Mustafa ZU, Hasan SS. The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021;1-7.
Kow CS, Hasan SS. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis. 2021;1-6.
Kow CS, Doi SAR, Hasan SS. The coincidence of increased risk of atrial fibrillation in randomized control trials of omega-3 fatty acids: a meta-analysis. Expert Rev Clin Pharmacol. 2021;1-3.
Kow CS, Hasan SS. Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19: a meta-analysis. J Asthma. 2021;1-4.
Kow CS, Hasan SS. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2021;1-6.
Rabeea SA, Merchant HA, Khan MU, Kow CS, Hasan SS. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021;1-5.
Mustafa ZU, Kow CS, Hasan SS. Effect of COVID-19 on viral hepatitis services in Pakistan. Lancet Gastroenterol Hepatol. 2021;6(3):163-164.
Hasan SS, Bal N, Baker I, Kow CS, Khan MU. Adverse Drug Reaction Reporting and Prescribing Trends of Drugs for Attention Deficit Hyperactivity Disorder in Primary Care England, 2010-2019. J Atten Disord. 2021;1087054721997556.
Coromilas EJ, Kochav S, Kow CS, et al. Worldwide Survey of COVID-19 Associated Arrhythmias. Circ Arrhythm Electrophysiol. 2021;10.1161/CIRCEP.120.009458.
Merchant HA, Kow CS, Hasan SS. COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021;1-6.
Kow CS, Aldeyab M, Hasan SS. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021;77(3):435-437.
Hasan SS, Kow CS, Zaidi STR. Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures?. Res Social Adm Pharm. 2021;17(2):456-459.
Kow CS, Hasan SS. A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19. Therapie. 2020;S0040-5957(20)30241-9.
Mazhar F, Hadi MA, Kow CS, Marran AMN, Merchant HA, Hasan SS. Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?. Int J Infect Dis. 2020;101:107-120.
Kow CS, Aldeyab M, Hasan SS. Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials. J Med Virol. 2021;93(4):1860-1861.
Hasan SS, Kow CS, Hadi MA, Zaidi STR, Merchant HA. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020;20(6):571-590.
Kow CS, Capstick T, Zaidi STR, Hasan SS. Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients. Eur J Hosp Pharm. 2021;28(1):42-46.
Kow CS, Hasan SS. Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol. 2021 Feb;93(2):695-697.
Hasan SS, Radford S, Kow CS, Zaidi STR. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020;50(4):814-821.
Kow CS, Hasan SS. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis. J Intern Med. 2021;289(1):125-128.
Kow CS, Hasan SS. Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020;134:153-155.
Kow CS, Hasan SS, Thiruchelvam K, Aldeyab M. Association of frailty and mortality in patients with COVID-19: a meta-analysis. Br J Anaesth. 2021;126(3):e108-e110.
Kow CS, Hasan SS. Prevalence of frailty in patients with covid-19: a meta-analysis. J Frailty Aging. 2021;10(2):189-190.
Hasan SS, Capstick T, Kow CS, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(11):1149-1163.
Hasan SS, Kow CS, Curley LE, Baines D, Babar ZU. Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults. Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):371-377.
Hasan SS, Kow CS, Dawoud D, Mohamed O, Baines D, Babar ZU. Pharmaceutical policy reforms to regulate drug prices in Asia Pacific Region: The case of Australia, China, India, Malaysia, New Zealand and South Korea. Value Health Reg Issues. 2018 Nov 6;18:18-23.
Hasan SS, Kow CS, Chong DWK, Ahmed SI. An evaluation of medication appropriateness and frailty among aged care homes residents living with chronic diseases. Medicine (Baltimore). 2017 Sep;96(35):e7929.
Hasan SS, Thiruchelvam K, Kow CS, Ghori M, Babar ZU. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):431-439.
Hasan SS, Kow CS, Chong DWK. An evaluation of central nervous system (CNS) medication use and frailty among Malaysian aged care homes residents. Neuroepidemiology. 2017;49(1-2):82-90.
Book / Book Chapters
Hasan SS, Kow CS. High Cost Medicines: Access, Affordability, and Prices. In: Encyclopedia of Pharmacy Practice and Clinical Pharmacy, Elsevier, 2019.
2016 - 2017: Syed Shahzad Hasan, David Chong Weng Kwai, Syed Imran Ahmed, Kow Chia Siang (The Effect of Frailty on Clinical Outcomes and Quality of Life in Older People), International Medical University, Malaysia, (RM 9,000.00)
2020-2021: Rohit Kumar Verma, Wong Pei Se, Kow Chia Siang (Quality and concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia) International Medical University, Malaysia, (RM 7,450.00)
The Lancet Global Health
BMC Family Practice
Journal of Pharmacy Practice
Archives Of Physiology And Biochemistry
Medical Science Monitor
Expert Review of Respiratory Medicine
Expert Review of Pharmacoeconomics & Outcomes Research
Malaysian Pharmacists Society - Immunisation Advocacy Chapter (Research and Publication)